News | May 04, 2010

Stereotactic Radiosurgery Found Successul in Treating Neuromas

April 4, 2010 - Each year, Mayo Clinic neurologists and neurosurgeons care for more than 2,200 patients with brain and nervous system tumors, including many with acoustic neuromas, noncancerous tissue growth that arises on a cranial nerve leading from the brain to the inner ear. Treatment options include observation, surgical removal and stereotactic radiosurgery.

In a new Mayo Clinic study, researchers found Gamma Knife’s stereotactic radiosurgery successfully treats the majority of patients who have large acoustic neuromas. This study was presented at the American Association of Neurological Surgeons Annual Meeting in Philadelphia this week.

Gamma Knife stereotactic radiosurgery performs neurosurgery without an incision. In the study, the Mayo Clinic neurosurgeons used gamma radiation to destroy diseased tissue, while preserving the surrounding healthy tissue. The procedure is typically short and allows most patients to be discharged from the hospital the same day.

A team of Mayo Clinic researchers collected data from 34 patients who had Gamma Knife stereotactic radiosurgery for a large acoustic neuroma between 1997 and 2006. These individuals' acoustic neuromas represented tumor volumes that were considered large (one standard deviation above the mean). At three years, 89.4 percent of these patients had not experienced tumor progression, 91.6 percent were free of new facial neuropathy and 52.8 percent had preserved functional hearing. At five years, the rates decreased to 82.9 percent with no tumor recurrence or progression, 86.4 percent free of new facial neuropathy and 34.5 percent with preserved functional hearing. At the most recent follow-up, 85 percent of the tumors were smaller than at the time of stereotactic radiosurgery.

For more information: www.mayoclinic.org/stereotactic-radiosurgery/gamma-knife.htm

Related Content

more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017
A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the...
ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the use of...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
Stereotactic Radiation Highly Effective for Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | May 03, 2017
Kidney cancer patients may soon have an alternative to traditional treatments, according to new research at UT...
SBRT, stereotactic body radiation therapy, early-stage lung cancer, patients 80 and older, 2017 Multidisciplinary Thoracic Cancers Symposium, study
News | Stereotactic Body Radiation Therapy (SBRT) | March 20, 2017
Patients in their 80s and 90s who have early-stage lung cancer but cannot undergo an operation can be treated safely...
prostate cancer, partial gland, SBRT, clinical trial, UH Hospitals
News | Stereotactic Body Radiation Therapy (SBRT) | April 28, 2016
Physicians at University Hospitals Seidman Cancer Center (Cleveland) have started a clinical trial using a new form of...
prostate cancer, stereotactic body radiation therapy, SBRT, cure rate, UT Southwestern Study
News | Prostate Cancer | April 19, 2016
A five-year study shows that stereotactic body radiation therapy (SBRT) offers a higher cure rate for prostate cancer...
Overlay Init